Medical Weight Management
Tirzepatide / Mounjaro Medical Weight Management
A clinician-supervised treatment pathway for suitable patients seeking medical support with weight loss and appetite regulation.
What it may support
Who it may suit
Process
Expectations
Pricing
Aftercare
How this differs
Tirzepatide acts on both GIP and GLP-1 pathways, while Semaglutide acts on GLP-1 pathways.
At Arziki, this treatment is considered only after consultation, suitability review and discussion of realistic expectations. Pricing is provided after assessment because the treatment area, product or device used, number of sessions, dosage where relevant and the personalised plan may vary.
Every patient responds differently. Your treatment plan, suitability and expectations are discussed during consultation.
Common questions
Quick answers to common questions about this treatment. For anything specific to you, the consultation is the right place to discuss it.
- Do I need to know I want Tirzepatide / Mounjaro Medical Weight Management before booking?
- No. You can start with a concern or goal and the team will guide you through the suitable options, including whether this treatment is the right route for you.
- Why is the price not shown on this page?
- Provided after consultation because medication suitability, dose, monitoring needs and treatment duration vary.
- How will I know what to expect after treatment?
- Monitoring should include side-effect review, progress tracking and adjustment of the plan where appropriate.
- What if this treatment is not suitable for me?
- Suitability is reviewed in consultation. If this is not the right route, the team will explain what may suit you instead — including saying not yet where appropriate.
Related treatments
Related concerns
Prefer to start from your concern rather than the treatment? These pages are a useful next step.
Ready to start with clarity?
Book a consultation and receive clear, clinician-led guidance on the most suitable next step for your goals.